Ruxience 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung

7680697010013 CH-69701 Konzentrat
Ruxience 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Ruxience 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Ruxience 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
19/08/2025
Summary of Product Characteristics
Français
19/08/2025
Summary of Product Characteristics
Italien
19/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.07 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 237.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2025

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69701
Drug name
Ruxience, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FA01
Authorization status
Z
Dispensing category
A
First authorization
19/08/2024
Authorization expiration date
18/08/2029
IT Number
07.16.1.
Domain
Human medicine
Field of application
Non-Hodgkin-Lymphom, Rheumatoide Arthritis, ANCA-assoziierte Vaskulitis, Pemphigus vulgaris

Package details

Description (FR)
RUXIENCE conc perf 100 mg/10ml vial 10 ml
Description (DE)
RUXIENCE Inf Konz 100 mg/10ml Vial 10 ml
Market launch
19/08/2024
Narcotic (BTM)
No

Other package sizes (2)

RUXIENCE 100 mg/10 ml conc perf 100 mg 2x1 pce
2 x 1 DUR
GTIN: 7680697010037
Not in V1
RUXIENCE conc perf 500 mg/50ml vial 50 ml
1 DUR
GTIN: 7680697010020
View